February 8, 2024 · Form 4 insider transaction
Gregory Ginger bought 1,635 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.